Radiolabeled Compounds for Diagnosis and Treatment of Cancer
Radiopharmaceuticals are used in the diagnosis and treatment of various diseases, especially cancer. In general, radiopharmaceuticals are either salts of radionuclides or radionuclides bound to biologically active molecules, drugs, or cells. Tremendous progress has been made in discovering, developi...
Bewaard in:
| Formaat: | Online |
|---|---|
| Taal: | Engels |
| Gepubliceerd in: |
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
| Onderwerpen: | |
| Online toegang: | ONIX_20220111_9783036524276_880 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
| _version_ | 1869525223892582400 |
|---|---|
| collection | Directory of Open Access Books |
| description | Radiopharmaceuticals are used in the diagnosis and treatment of various diseases, especially cancer. In general, radiopharmaceuticals are either salts of radionuclides or radionuclides bound to biologically active molecules, drugs, or cells. Tremendous progress has been made in discovering, developing, and commercializing numerous radiopharmaceuticals for the imaging and therapy of cancer. Significant research is ongoing in academia and the pharmaceutical industry to develop more novel radiolabeled compounds as potential radiopharmaceuticals for unmet needs. This Special Issue aims to focus on all aspects of the design, characterization, evaluation, and development of novel radiolabeled compounds for the diagnosis and treatment of cancer and the application of new radiochemistry and methodologies for the development of novel radiolabeled compounds. Outstanding contributions presented in this Special Issue will significantly add to the field of radiopharmaceuticals. |
| format | Online |
| id | doab-20.500.12854ir-77048 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2022 |
| publishDateRange | 2022 |
| publishDateSort | 2022 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-770482024-03-28T03:32:54Z Radiolabeled Compounds for Diagnosis and Treatment of Cancer Kumar, Krishan positron emission tomography (PET) pyrazoles fluorine-18 radionuclides PET probes imaging pharmaceuticals hypopharyngeal cancer 188Re-liposome repeated therapy NGS microRNA aprepitant radiopharmaceuticals neurokinin 1 receptor antagonist radionuclide chelators kidney uptake cleavable linkers neutral endopeptidase (NEP) renal brush border enzymes prostate-specific membrane antigen (PSMA) cancer imaging and therapy somatostatin analogs radiolabeling radionuclide therapy imaging adrenergic receptor positron emission tomography radiotracer cholecystokinin-2 receptor minigastrin molecular imaging targeted radiotherapy lutetium-177 EpCAM radionuclide SPECT iodine PIB breast cancer PET target-specific biomolecules immunoPET imaging pharmaceuticals production processes 124I-labeled monoclonal antibodies radiotracers AAZTA scandium-44 FAP SA DPP PREP radioiodine labeling radioiodination biomolecules peptides proteins monoclonal antibodies 123,124,125,131I-labeled molecules and biomolecules n/a thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general thema EDItEUR::P Mathematics and Science::PN Chemistry Radiopharmaceuticals are used in the diagnosis and treatment of various diseases, especially cancer. In general, radiopharmaceuticals are either salts of radionuclides or radionuclides bound to biologically active molecules, drugs, or cells. Tremendous progress has been made in discovering, developing, and commercializing numerous radiopharmaceuticals for the imaging and therapy of cancer. Significant research is ongoing in academia and the pharmaceutical industry to develop more novel radiolabeled compounds as potential radiopharmaceuticals for unmet needs. This Special Issue aims to focus on all aspects of the design, characterization, evaluation, and development of novel radiolabeled compounds for the diagnosis and treatment of cancer and the application of new radiochemistry and methodologies for the development of novel radiolabeled compounds. Outstanding contributions presented in this Special Issue will significantly add to the field of radiopharmaceuticals. 2022-01-11T13:50:27Z 2022-01-11T13:50:27Z 2021 book ONIX_20220111_9783036524276_880 9783036524276 9783036524269 https://directory.doabooks.org/handle/20.500.12854/77048 eng image/jpeg Attribution 4.0 International https://mdpi.com/books/pdfview/book/4658 https://mdpi.com/books/pdfview/book/4658 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-2426-9 10.3390/books978-3-0365-2426-9 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036524276 9783036524269 262 Basel, Switzerland open access |
| spellingShingle | positron emission tomography (PET) pyrazoles fluorine-18 radionuclides PET probes imaging pharmaceuticals hypopharyngeal cancer 188Re-liposome repeated therapy NGS microRNA aprepitant radiopharmaceuticals neurokinin 1 receptor antagonist radionuclide chelators kidney uptake cleavable linkers neutral endopeptidase (NEP) renal brush border enzymes prostate-specific membrane antigen (PSMA) cancer imaging and therapy somatostatin analogs radiolabeling radionuclide therapy imaging adrenergic receptor positron emission tomography radiotracer cholecystokinin-2 receptor minigastrin molecular imaging targeted radiotherapy lutetium-177 EpCAM radionuclide SPECT iodine PIB breast cancer PET target-specific biomolecules immunoPET imaging pharmaceuticals production processes 124I-labeled monoclonal antibodies radiotracers AAZTA scandium-44 FAP SA DPP PREP radioiodine labeling radioiodination biomolecules peptides proteins monoclonal antibodies 123,124,125,131I-labeled molecules and biomolecules n/a thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general thema EDItEUR::P Mathematics and Science::PN Chemistry Radiolabeled Compounds for Diagnosis and Treatment of Cancer |
| title | Radiolabeled Compounds for Diagnosis and Treatment of Cancer |
| title_full | Radiolabeled Compounds for Diagnosis and Treatment of Cancer |
| title_fullStr | Radiolabeled Compounds for Diagnosis and Treatment of Cancer |
| title_full_unstemmed | Radiolabeled Compounds for Diagnosis and Treatment of Cancer |
| title_short | Radiolabeled Compounds for Diagnosis and Treatment of Cancer |
| title_sort | radiolabeled compounds for diagnosis and treatment of cancer |
| topic | positron emission tomography (PET) pyrazoles fluorine-18 radionuclides PET probes imaging pharmaceuticals hypopharyngeal cancer 188Re-liposome repeated therapy NGS microRNA aprepitant radiopharmaceuticals neurokinin 1 receptor antagonist radionuclide chelators kidney uptake cleavable linkers neutral endopeptidase (NEP) renal brush border enzymes prostate-specific membrane antigen (PSMA) cancer imaging and therapy somatostatin analogs radiolabeling radionuclide therapy imaging adrenergic receptor positron emission tomography radiotracer cholecystokinin-2 receptor minigastrin molecular imaging targeted radiotherapy lutetium-177 EpCAM radionuclide SPECT iodine PIB breast cancer PET target-specific biomolecules immunoPET imaging pharmaceuticals production processes 124I-labeled monoclonal antibodies radiotracers AAZTA scandium-44 FAP SA DPP PREP radioiodine labeling radioiodination biomolecules peptides proteins monoclonal antibodies 123,124,125,131I-labeled molecules and biomolecules n/a thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general thema EDItEUR::P Mathematics and Science::PN Chemistry |
| topic_facet | positron emission tomography (PET) pyrazoles fluorine-18 radionuclides PET probes imaging pharmaceuticals hypopharyngeal cancer 188Re-liposome repeated therapy NGS microRNA aprepitant radiopharmaceuticals neurokinin 1 receptor antagonist radionuclide chelators kidney uptake cleavable linkers neutral endopeptidase (NEP) renal brush border enzymes prostate-specific membrane antigen (PSMA) cancer imaging and therapy somatostatin analogs radiolabeling radionuclide therapy imaging adrenergic receptor positron emission tomography radiotracer cholecystokinin-2 receptor minigastrin molecular imaging targeted radiotherapy lutetium-177 EpCAM radionuclide SPECT iodine PIB breast cancer PET target-specific biomolecules immunoPET imaging pharmaceuticals production processes 124I-labeled monoclonal antibodies radiotracers AAZTA scandium-44 FAP SA DPP PREP radioiodine labeling radioiodination biomolecules peptides proteins monoclonal antibodies 123,124,125,131I-labeled molecules and biomolecules n/a thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general thema EDItEUR::P Mathematics and Science::PN Chemistry |
| url | ONIX_20220111_9783036524276_880 |